Neuronetics announces Evernorth Health expanded its coverage of NeuroStar TMS

Neuronetics (STIM) announced that Evernorth Health Services, a wholly owned subsidiary of The Cigna Group, has expanded its coverage of NeuroStar Transcranial Magnetic Stimulation, TMS, to include adolescents aged 15 and older living with major depressive disorder, MDD. As these health policies cover 15 million lives, the expansion greatly improves access to non-drug treatment options for adolescent patients who are seeking non-drug options for depression.